Home
/ Tikcro
/ Competitors

Tikcro Competitors and Similar CompaniesClear all

Tikcro's competitors and similar companies include OncoArendi Therapeutics, Alligator Bioscience, BioAtla and Luye Pharma.

	Tikcro Tikcro Technologies is a company that specializes in antibody generation for cancer immunotherapy.	OncoArendi Therapeutics OncoArendi Therapeutics is a biotech company focused on discovery and development of small molecule drug candidates.	Alligator Bioscience Alligator develops antibody-based pharmaceuticals for cancer treatment.	BioAtla BioAtla is a biopharmaceutical company that develops antibody-based therapeutics for the treatment of solid tumor cancer.	Luye Pharma Luye Pharma Group (绿叶制药) is a pharmaceutical company that develops, manufactures, and sells medications.
Founding Date	Founding Date 1999	Founding Date 2012	Founding Date 2001	Founding Date 2007	Founding Date 1994
Type	Type Private	Type Private	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy
Locations	Locations Ness Ziona, IL HQ	Locations Warszawa, PL HQ Łódź, PL	Locations Lund, SE HQ	Locations San Diego, US HQ	Locations CN HQ
Employees	Employees 4	Employees 839% increase	Employees 1555% decrease	Employees 616% decrease	Employees 5,150
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 59 m	Valuation ($) 100.8 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) kr514k (FY, 2025)	Revenue (est.) N/A	Revenue (est.) ¥6.3b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥1.3b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit kr1.1m (FY, 2025)	Gross profit N/A	Gross profit ¥5.1b (FY, 2025)
Net income	Net income ($929k) (FY, 2019)	Net income N/A	Net income (kr51.4m) (FY, 2025)	Net income ($59.6m) (FY, 2025)	Net income ¥705.7m (FY, 2025)